Exenatide Protects against glucose- and lipid-induced endothelial dysfunction: evidence for direct vasodilation effect of GLP-1 receptor agonists in humans
Its not an FDA-approved drug, and buying it outside the regulated supply chain means you have no idea whats really in it
First, Retatrutide turns on GLP-1 receptors
The dose-findings studies reported here not only documented the superior efficacy of GLP1/E in the management of metabolic alterations in our obese PCOS model, including lowering body weight and adiposity, as well as improvement of glucose handling and insulin resistance, but also highlighted a non-monotonic effect of this dual agonist in PNA mice, with optimal effects being achieved with submaximal doses
Detailed body composition data shows lean mass losses of approximately 6.5 kg occurred alongside fat mass reductions exceeding 10 kg with higher doses
Tirzepatides insulinotropic effects on human islets depend on GIPR activity, according to Ei et al
